EGFR mutations subset in Chinese lung squamous cell carcinoma patients

Research has identified that epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) possess large benefits for adenocarcinoma (ADC), although little benefit for squamous cell carcinoma (SCC). The aim of the present study was to investigate the percentage of patients with SCC with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Med Rep
Main Authors: Sun, Ying, Yin, Xin, Wen, Miao-Miao, Zhang, Jiao, Wang, Xue-Jiao, Xia, Jing-Hua, Zhang, Yan-Ning, Zhang, Zhi-Pei, Li, Xiao-Fei
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2018
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5983943/
https://ncbi.nlm.nih.gov/pubmed/29620244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2018.8859
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados